Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion type Assertion NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_head.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion description "[To determine the durability of complete responses in patients with metastatic melanoma or renal cancer treated with high-dose bolus interleukin-2 (IL-2) as well as the factors associated with the development of a complete response and the antigens mediating clinical responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_provenance.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion evidence source_evidence_literature NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_provenance.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion SIO_000772 9742914 NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_provenance.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion wasDerivedFrom befree-20150227 NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_provenance.
- NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_assertion wasGeneratedBy ECO_0000203 NP493098.RAdRBySTAJzFvP1u8_3yVY2_V3LJZNjCp-QsYfh8zi8zg130_provenance.